Joseph Beaulieu
Geen lopende functies
Profiel
Joseph Beaulieu worked as an Associate Director at Morningstar, Inc. from 2009 to 2011.
Prior to that, he worked as an Analyst at ABN AMRO Securities (USA), Inc. in 1999.
Currently, he is the Treasurer & Controller at Epizyme, Inc. since 2018.
Mr. Beaulieu completed his undergraduate degree at The University of Chicago and his graduate degree at the University of Illinois.
He also completed an undergraduate degree at the Wallace E Carroll School of Management.
Eerdere bekende functies van Joseph Beaulieu
| Bedrijven | Functie | Einde |
|---|---|---|
| EPIZYME, INC. | Comptroller/Controller/Auditor | 01-02-2023 |
Morningstar, Inc. (Research)
 Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Director of Research - Equity | 31-08-2011 |
| ABN AMRO Securities (USA), Inc. | Analyst-Equity | 31-10-1999 |
Opleiding van Joseph Beaulieu
| The University of Chicago | Undergraduate Degree |
| University of Illinois | Graduate Degree |
| Wallace E Carroll School of Management | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| ABN AMRO Securities (USA), Inc. | Finance |
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
